[PDF] Top 20 平成17年3月期 第3四半期 財務・業績の概況（連結） 決算短信 | IRライブラリー | 株主・投資家の皆様へ | アマノ
Has 10000 "平成17年3月期 第3四半期 財務・業績の概況（連結） 決算短信 | IRライブラリー | 株主・投資家の皆様へ | アマノ" found on our website. Below are the top 20 most common "平成17年3月期 第3四半期 財務・業績の概況（連結） 決算短信 | IRライブラリー | 株主・投資家の皆様へ | アマノ".
Antiplatelet activity of Staphylococcus aureus lipoteichoic acid is mediated through a cyclic AMP pathway
... In this study, Gram-positive Staphylococcus aureus lipoteichoic acid (LTA) dose dependently (0.1-1.0 microg/mL) and time dependently (10-60 min) inhibited platelet aggregation in human[r] ... 完全なドキュメントを参照
2
Antiplatelet activity of staphylococcus aureus lipoteichoic acid is mediated through a cyclic AMP pathway
... Gram-positive Staphylococcus aureus ence Ltd. All rights reserved. lipoteichoic acid (LTA) dose dependently ...gation; Cyclic AMP; Protein kinase ... 完全なドキュメントを参照
Antiplatelet activity of staphylococcus aureus lipoteichoic acid is mediated through a cyclic AMP pathway
... Gram-positive Staphylococcus aureus ence Ltd. All rights reserved. lipoteichoic acid (LTA) dose dependently ...gation; Cyclic AMP; Protein kinase C lated by agonists ...as ... 完全なドキュメントを参照
Antiplatelet Activity of Staphylococcus aureus Lipoteichoic Acid Is Mediated Through a Cyclic AMP Pathway
... In this study, Gram-positive Staphylococcus aureus lipoteichoic acid (LTA) dose dependently (0.1-1.0 microg/mL) and time dependently (10-60 min) inhibited platelet aggregation in human[r] ... 完全なドキュメントを参照
9
Antiplatelet activity of caffeic acid phenethyl ester is mediated through a cyclic GMP-dependent pathway in human platelets.
... The present study reports a novel and potent antiplatelet agent, CAPE, which involved in the following inhibitory pathways: CAPE increases cyclic GMP/VASP Ser157 phosphorylation, and s[r] ... 完全なドキュメントを参照
3
Mechanism Involved in the Antiplatelet Activity of Staphylococcus aureus Lipoteichoic Acid in Human Platelet
... Mechanism Involved in the Antiplatelet Activity of Staphylococcus aureus Lipoteichoic Acid in Human Platelet.. 蕭哲志.[r] ... 完全なドキュメントを参照
8
Mechanisms involved in antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets.
... These results indicate that the antiplatelet activity of LTA may be involved in the following pathways: LTA's effects may initially be due to induction of conformational changes in the[r] ... 完全なドキュメントを参照
1
The antiplatelet activity of Escherichia coli lipopolysaccharide is mediated through a nitric oxide/cyclic GMP pathway.
... In this study, Escherichia coli LPS dose-dependently (100-500 μg/ ml) and time- dependently (10-60 min) inhibited platelet aggregation in human and rabbit platelets stimulated by agonis[r] ... 完全なドキュメントを参照
The antiplatelet activity of escherichia coli lipopolysaccharide is mediated through a nitric oxide/cyclic GMP pathway.
... formation of cyclic GMP but not cyclic AMP in ...production of nitrate within a 10-min incubation ...nmol/l), a protein kinase C ...the antiplatelet activity ... 完全なドキュメントを参照
2
Mechanisms involved in the antiplatelet activity of staphylococcus aureaus lipoteichoic acid in human platelets
... These results indicate that the antiplatelet activity of LTA may be involved in the following pathways: LTA's effects may initially be due to induction of conformational changes in th[r] ... 完全なドキュメントを参照
3
The Antiplatelet activity of ketamine is mediated through suppression of phosphoinositide breakdown and an increase in cyclic GMP.
... In this study, Escherichia coli LPS dose-dependently (100-500 μg/ ml) and time- dependently (10-60 min) inhibited platelet aggregation in human and rabbit platelets stimulated by agonis[r] ... 完全なドキュメントを参照
The Antiplatelet activity of ketamine is mediated through suppression of phosphoinositide breakdown and an increase in cyclic GMP.
... coli LPS may be involved in the activation of a nitric oxide/cyclic GMP pathway in platelets, resulting in inhibition of platelet aggregation. Therefore, LPS-mediated alteration of pla[r] ... 完全なドキュメントを参照
α-Naphthoflavone, a Potent Antiplatelet Flavonoid, Is Mediated through Inhibition of Phospholipase C Activity and Stimulation of Cyclic GMP Formation
... (1) α-NF may inhibit the activation of phospholipase C, followed by inhibition of phosphoinositide breakdown, protein kinase C activation, and thromboxane A2 formation, thereby leading[r] ... 完全なドキュメントを参照
4
alpha-Naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation.
... (1) alpha-NF may inhibit the activation of phospholipase C, followed by inhibition of phosphoinositide breakdown, protein kinase C activation, and thromboxane A(2) formation, thereby l[r] ... 完全なドキュメントを参照
2
Alpha-naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation.
... alpha-NF (5 and 10 microM) inhibited intracellular Ca(2+) mobilization, phosphoinositide breakdown, and thromboxane A(2) formation stimulated by collagen (1 microg/mL) in human platele[r] ... 完全なドキュメントを参照
Alpha-naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation.
... (1) alpha-NF may inhibit the activation of phospholipase C, followed by inhibition of phosphoinositide breakdown, protein kinase C activation, and thromboxane A(2) formation, thereby l[r] ... 完全なドキュメントを参照
The antiplatelet activity of tetramethylpyrazine is mediated through activation of NO synthase.
... Furthermore, TMPZ concentration (50 and 200m M)- and time (15 and 30 min)-dependently triggered endothelial- type constitutive nitric oxide synthase (ecNOS) protein expr[r] ... 完全なドキュメントを参照
The antiplatelet activity of tetramethylpyrazine is mediated through activation of NO synthase.
... Furthermore, TMPZ concentration (50 and 200m M)- and time (15 and 30 min)-dependently triggered endothelial- type constitutive nitric oxide synthase (ecNOS) protein expression in huma[r] ... 完全なドキュメントを参照
The hyperaggregability of platelets from normal pregnancy is mediated through thromboxane A2 and cyclic AMP pathways
... There is substantial evidence of increased platelet reactivity in vivo and in vitro during pregnancy, with the risk of developing ...weeks of gestation in a group of women who ... 完全なドキュメントを参照
The hyperaggregability of platelets from normal pregnancy is mediated through thromboxane A2 and cyclic AMP pathways
... There is substantial evidence of increased platelet reactivity in vivo and in vitro during pregnancy, with the risk of developing ...weeks of gestation in a group of women who ... 完全なドキュメントを参照
関連した話題